Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anchor Molecular is a private U.S. life science diagnostics company that develops and sells quality controls, reference materials, and assay-support reagents for molecular testing and in vitro diagnostic assay development. Its product portfolio is centered on oncology liquid biopsy and NGS workflows, including ctDNA and cfDNA standards, extraction controls, RNA fusion panels, and molecular controls for virology and other clinical testing applications. The company also provides custom reference materials for clinical laboratories and assay developers seeking to validate, monitor, and improve assay performance. Rather than developing therapeutics, Anchor Molecular operates as a commercial tools and diagnostics supplier supporting molecular diagnostics, especially liquid biopsy, oncology, NIPT, and infectious disease testing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anchor Molecular.